Literature DB >> 11833862

Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea.

David Gozal1, Andrew J Lipton, Kimberly L Jones.   

Abstract

STUDY
OBJECTIVES: Obstructive sleep apnea (OSA) is associated with intermittent hypoxia during sleep. Vascular endothelial growth factor (VEGF) has detectable levels in the circulation and its expression is highly regulated by oxygen tension. We therefore hypothesized that serum VEGF levels will be elevated in patients with OSA.
DESIGN: Blood samples were collected at random times during the day from 68 adults and 41 children who were clinically suspected for the presence of OSA, and who underwent overnight polysomnography.
SETTING: University hospital sleep laboratory. PARTICIPANTS: N/A.
INTERVENTIONS: N/A. MEASUREMENTS AND
RESULTS: For both children and adults, serum VEGF levels were significantly higher in polysomnographically confirmed OSA (AHI>15 and AI>5 in adults and children respectively) when compared to those with mild or no disease (p<0.0001). Furthermore, significant correlations were found between VEGF concentrations and respiratory disturbance index and sleep time spent at SpO2 <90%. In addition, VEGF levels in children were higher for any given duration of hypoxia during sleep (p<0.0001). No differences in VEGF emerged between evening and morning samples. However, temporal delays in blood sample processing were associated with spuriously increased VEGF concentrations. Exploratory analysis of the data revealed that serum VEGF concentrations of >150 pg/ml in adults and >100 pg/ml in children were predictive of OSA, when an apnea-hypopnea index >30 and an apnea index >5 were used as disease criteria in adults and children, respectively.
CONCLUSIONS: We conclude that circulating VEGF levels are frequently elevated in OSA patients, and may play a role in the regulation of tissue oxygen delivery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11833862     DOI: 10.1093/sleep/25.1.59

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  42 in total

1.  Altered in vitro endothelial repair and monocyte migration in obstructive sleep apnea: implication of VEGF and CRP.

Authors:  Anne Briançon-Marjollet; Marion Henri; Jean-Louis Pépin; Emeline Lemarié; Patrick Lévy; Renaud Tamisier
Journal:  Sleep       Date:  2014-11-01       Impact factor: 5.849

2.  Guidelines for diagnosing and treating sleep related breathing disorders in adults and children (Part 3: obstructive sleep apnea in children, diagnosis and treatment).

Authors:  V Tsara; A Amfilochiou; J M Papagrigorakis; D Georgopoulos; E Liolios; A Kadiths; E Koudoumnakis; E Aulonitou; M Emporiadou; M Tsakanikos; A Chatzis; M Choulakis; G Chrousos
Journal:  Hippokratia       Date:  2010-01       Impact factor: 0.471

Review 3.  Pediatric sleep apnea: implications of the epidemic of childhood overweight.

Authors:  Carolyn E Ievers-Landis; Susan Redline
Journal:  Am J Respir Crit Care Med       Date:  2006-12-07       Impact factor: 21.405

4.  Oropharyngeal exercises to reduce symptoms of OSA after AT.

Authors:  Maria Pia Villa; Luca Brasili; Alessandro Ferretti; Ottavio Vitelli; Jole Rabasco; Anna Rita Mazzotta; Nicoletta Pietropaoli; Susy Martella
Journal:  Sleep Breath       Date:  2014-05-26       Impact factor: 2.816

Review 5.  Biomarkers associated with obstructive sleep apnea: A scoping review.

Authors:  Graziela De Luca Canto; Camila Pachêco-Pereira; Secil Aydinoz; Paul W Major; Carlos Flores-Mir; David Gozal
Journal:  Sleep Med Rev       Date:  2014-11-28       Impact factor: 11.609

6.  Leukocyte telomere length and plasma catestatin and myeloid-related protein 8/14 concentrations in children with obstructive sleep apnea.

Authors:  Jinkwan Kim; Seungkwan Lee; Rakesh Bhattacharjee; Abdelnaby Khalyfa; Leila Kheirandish-Gozal; David Gozal
Journal:  Chest       Date:  2010-03-18       Impact factor: 9.410

Review 7.  Obstructive sleep apnea and cognitive impairment: addressing the blood-brain barrier.

Authors:  Diane C Lim; Allan I Pack
Journal:  Sleep Med Rev       Date:  2013-03-28       Impact factor: 11.609

8.  Nocturnal change of circulating intercellular adhesion molecule 1 levels in children with snoring.

Authors:  Athanasios G Kaditis; Emmanouel I Alexopoulos; Efthimia Kalampouka; Fotini Hatzi; Ioanna Karadonta; Theodoros Kyropoulos; Dimitrios G Kaditis; Konstantinos Gourgoulianis; George A Syrogiannopoulos
Journal:  Sleep Breath       Date:  2007-12       Impact factor: 2.816

9.  Obstructive sleep apnea and acute myocardial infarction severity: ischemic preconditioning?

Authors:  Neomi Shah; Susan Redline; H Klar Yaggi; Richard Wu; C George Zhao; Robert Ostfeld; Mark Menegus; Daniel Tracy; Elizabeth Brush; W David Appel; Robert C Kaplan
Journal:  Sleep Breath       Date:  2012-10-23       Impact factor: 2.816

10.  Serum omentin levels in patients with obstructive sleep apnea.

Authors:  Ozlem Kar Kurt; Mehmet Tosun; Aytekin Alcelik; Beyhan Yilmaz; Fahrettin Talay
Journal:  Sleep Breath       Date:  2013-10-03       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.